B cells

B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis
Laetitia Rapetti, Konstantia-Maria Chavele, Catherine M Evans, Michael R Ehrenstein

Annals of the Rheumatic Diseases Jan 2015, 74 (1) 294-302; DOI: 10.1136/annrheumdis-2013-204049
Lymphocyte changes and vaccination response in a child exposed to belimumab during pregnancy
Helle Bitter, Anne Noraas Bendvold, Monika Elisabeth Østensen

Annals of the Rheumatic Diseases Nov 2018, 77 (11) 1692-1693; DOI: 10.1136/annrheumdis-2018-213004
TLR4⁺CXCR4⁺ plasma cells drive nephritis development in systemic lupus erythematosus
Kongyang Ma, Jingyi Li, Xiaohui Wang, Xiang Lin, Wenhan Du, Xi Yang, Fangxiang Mou, Yongfei Fang, Yanbin Zhao, Xiaoping Hong, Kwok Wah Chan, Xiaoming Zhang, Dongzhou Liu, Lingyun Sun, Liwei Lu

Annals of the Rheumatic Diseases Oct 2018, 77 (10) 1498-1506; DOI: 10.1136/annrheumdis-2018-213615
‘MAINRITSAN2-the future’, with some doubts!
Arghya Chattopadhyay, Nupoor Acharya, Debashish Mishra, Vikas Sharma, GSRSNK Naidu, Aman Sharma

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e139; DOI: 10.1136/annrheumdis-2018-214486
Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sjögren’s syndrome
Lara A Aqrawi, Lara Mentlein, Lauro Meneghel, Albin Björk, Gudny Ella Thorlacius, Margarita Ivanchenko, Jorge I Ramírez Sepúlveda, Kathrine Skarstein, Marika Kvarnström, Susanna Brauner, Alexander Espinosa, Marie Wahren-Herlenius

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1840-1842; DOI: 10.1136/annrheumdis-2018-213634
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1
Andrew L Mammen, Arun Rajan, Katherine Pak, Tanya Lehky, Livia Casciola-Rosen, Renee N Donahue, Lauren M Lepone, Anastasia Zekeridou, Sean J Pittock, Raffit Hassan, Jeffrey Schlom, James L Gulley

Annals of the Rheumatic Diseases Jan 2019, 78 (1) 150-152; DOI: 10.1136/annrheumdis-2018-213777
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
David Isenberg, Caroline Gordon, Daiana Licu, Samuel Copt, Claudia Pena Rossi, David Wofsy

Annals of the Rheumatic Diseases Nov 2015, 74 (11) 2006-2015; DOI: 10.1136/annrheumdis-2013-205067
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
Joan T Merrill, William R Shanahan, Morton Scheinberg, Kenneth C Kalunian, David Wofsy, Renee S Martin

Annals of the Rheumatic Diseases Jun 2018, 77 (6) 883-889; DOI: 10.1136/annrheumdis-2018-213032
Response to: ‘Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome?’ by Coiffier et al
Sandrine Jousse-Joulin, Maria Antonietta D'Agostino, Alojzija Hočevar, Esperanza Naredo, Lene Terslev, Sarah Ohrndorf, Annamaria Iagnocco, Wolfgang A Schmidt, Stephanie Finzel, Zarrin Alavi, George A W Bruyn

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e112; DOI: 10.1136/annrheumdis-2019-216327
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease
Emanuel Della-Torre, Eoin Feeney, Vikram Deshpande, Hamid Mattoo, Vinay Mahajan, Maria Kulikova, Zachary S Wallace, Mollie Carruthers, Raymond T Chung, Shiv Pillai, John H Stone

Annals of the Rheumatic Diseases Dec 2015, 74 (12) 2236-2243; DOI: 10.1136/annrheumdis-2014-205799

Main menu

B cells

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

B cells

Pages